3.15

1.61% +0.0499

Neuraxis Inc (NRXS)

Overview News Price History Discussions Forecast

Neuraxis Inc stock is currently priced at $3.15, with a 24-hour trading volume of 1,876. It has seen a +1.61% increased in the last 24 hours and a -0.32% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $3.09 pivot point. If it approaches the $3.16 resistance level, significant changes may occur.

Previous Close:

$3.1001

Open:

$3.05

24h Volume:

1,876

Market Cap:

$20.44M

Revenue:

Net Income/Loss:

P/E Ratio:

-3.9053

EPS:

-0.8066

Net Cash Flow:

1W Performance:

-1.56%

1M Performance:

-0.32%

6M Performance:

+34.04%

1Y Performance:

+0.00%

1D Range:

$3.02

$3.145

52W Range:

$1.80

$5.45

Neuraxis Inc Stock (NRXS) Company Profile

Name

Neuraxis Inc

Sector

Healthcare (1219)

Industry

Biotechnology (700)

Phone

(812) 689-0791

Address

11550 North Meridian Street, Suite 325, Carmel

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NRXS's Discussions on Twitter

Neuraxis Inc Stock (NRXS) Latest News

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire Inc.

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

GlobeNewswire Inc.

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

GlobeNewswire Inc.

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

GlobeNewswire Inc.

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

GlobeNewswire Inc.

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

GlobeNewswire Inc.

Neuraxis Inc Stock (NRXS) Financials Data

There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.